As physicians across specialties encounter increasing patient interest in GLP-1 receptor agonists, it is important for them ...
Results presented at IDWeek showed prolonged antibiotic therapy beyond 12 weeks may not improve outcomes for early ...
In this video, Carolyn K. Pan, MD, a clinical professor of ophthalmology at Stanford University, discussed highlights in wet ...
Among adult patients and caregivers of pediatric patients with food allergy, self-reported anxiety and well-being were better ...
Pregnancy, menopause and hormone therapy may all impact a woman’s lipoprotein(a) level, challenging the mantra of the once-in ...
The past decade has seen a major shift in how thyroid cancer is diagnosed and managed. R. Michael Tuttle, MD, chief of ...
An AI model significantly improved recurrence risk stratification vs. recurrence score among patients with hormone ...
A pharmacy-based intervention may help increase SGLT2 inhibitor use for patients with type 2 diabetes and chronic kidney ...
Individuals with gout are more likely than those without the disease to receive chronic opioid therapy, independent of other ...
A greater proportion of women vs. men with COPD or bronchiectasis had their first health care visit within 6 months of ...
In this video, Matthew S. Davids, MD, spoke about the BRUIN-314 trial, one of the first head-to-head studies to compare pirtobrutinib, a noncovalent Bruton tyrosine kinase inhibitor, with ibrutinib, a ...
Milestone Pharmaceuticals announced the FDA approval of prescription etripamil nasal spray for the treatment of acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback